Prolonged higher dose methylprednisolone<i>versus</i>conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

202249 citationsJournal Articlehybrid Open Access

Authors

Prolonged, higher dose methylprednisolone did not reduce mortality at 28 days compared with conventional dexamethasone in COVID-19 pneumonia.

Good health and well-being

Published in: European Respiratory Journal

Volume 61, Issue 4, pp. 2201514-2201514

Field-Weighted Citation Impact: 4.65